Altimmune Announces Submission of Investigational New Drug Application for AdCOVID(TM) a Single-dose Intranasal COVID-19 Vaccine; On Track to Commence Phase 1 Clinical Study in December
Stock Information for Altimmune Inc.
Loading
Please wait while we load your information from QuoteMedia.